Update: Market Chatter: Bain, Cinven Said to Weigh Joint Bid for Sanofi's Consumer Health Division
(Adds potential separate bid from Advent, further details and attempts to reach companies for comment) Bain Capital and Cinven are considering a potential joint bid for Sanofi's (SNY) $20 billion cons
Christophe De Vusser Takes Office as Bain & Company's Worldwide Managing Partner and CEO
BOSTON and LONDON, July 1, 2024 /PRNewswire/ -- Bain & Company, one of the world's leading management consulting firms, today welcomes Christophe De Vusser as the firm's new Worldwide Managing Partne
Bain Capital Specialty Finance To Go Ex-Dividend On June 28th, 2024 With 0.42 USD Dividend Per Share And 0.03 USD Special Dividend Per Share
June 26th (Eastern Time) - $Bain Capital Specialty Finance(BCSF.US)$ is trading ex-dividend on June 28th, 2024.Shareholders of record on June 28th, 2024 will receive 0.42 USD dividend per share and 0.
Generative AI Virtually Ubiquitous in Global Business as the Technology Spreads at a Near-unprecedented Rate -- Bain & Company Proprietary Survey
9 in 10 companies have already deployed or are piloting generative AI technology Businesses are prioritizing AI deployments with multi-million-dollar budgets and people commitments Generative AI is m
Bain Capital is planning to offer $1.2 billion to acquire Bapcor, a retailer of auto parts, at a premium.
Global private equity giant Bain Capital has initiated the acquisition of Bapcor Ltd., a well-known auto parts retailer in Australia.
Yet Another Offer Could Emerge for Paramount's Controlling Company, WSJ Reports
By Bill Peters Edgar Bronfman Jr., with the backing of Bain Capital, is reportedly considering an offer up to $2.5 billion to buy National Amusements As media and entertainment giant Paramount Globa
Bain Capital to Acquire PowerSchool in $5.6 Billion Deal
07:48 AM EDT, 06/07/2024 (MT Newswires) -- Bain Capital to Acquire PowerSchool in $5.6 Billion Deal Price: 22.48, Change: +0.11, Percent Change: +0.49
Bain Capital Specialty Raised to Overweight From Equal-Weight by Wells Fargo
Bain Capital Specialty Raised to Overweight From Equal-Weight by Wells Fargo
Wells Fargo Upgrades Bain Capital Specialty to Overweight, Raises Price Target to $17
Wells Fargo analyst Finian O'Shea upgrades Bain Capital Specialty from Equal-Weight to Overweight and raises the price target from $16 to $17.
Wells Fargo Remains a Buy on Bain Capital Specialty Finance (BCSF)
Bain Capital Specialty Is Maintained at Market Perform by Keefe, Bruyette & Woods
Bain Capital Specialty Is Maintained at Market Perform by Keefe, Bruyette & Woods
Keefe, Bruyette & Woods Maintains Market Perform on Bain Capital Specialty, Raises Price Target to $17
Keefe, Bruyette & Woods analyst Ryan Lunch maintains Bain Capital Specialty (NYSE:BCSF) with a Market Perform and raises the price target from $16.5 to $17.
Express News | Bain Capital Specialty Finance Inc : KBW Raises Target Price to $17 From $16.5
Express News | Bain Capital Specialty Finance: Increased Commitments Under Senior Secured Revolving Credit Facility to $855 Mln & Extended Maturity to May 18, 2029
Bain Capital Specialty Finance, Inc. Increases and Extends Its Revolving Credit Facility
Bain Capital Specialty Finance, Inc. Increases and Extends Its Revolving Credit Facility May 22, 2024 BOSTON – May 22, 2024 – Bain Capital Specialty Finance, Inc. (NYSE: BCSF, the "Company
Bain Capital to Boost Japan Real Estate Team as Prospects Grow
(May 20): Bain Capital plans to bolster its real estate team in Japan, the latest global investment firm seeking to capitalize on opportunities in the nation's property market. The Boston-based firm needs more staff with expertise to source deals and to help manage or sell off real esta...
Wells Fargo Adjusts Bain Capital Specialty Finance Price Target to $16 From $15, Maintains Equal Weight Rating
Wells Fargo Adjusts Bain Capital Specialty Finance Price Target to $16 From $15, Maintains Equal Weight Rating.
Bain Capital Specialty Price Target Raised to $16.00/Share From $15.00 by Wells Fargo
Bain Capital Specialty Price Target Raised to $16.00/Share From $15.00 by Wells Fargo
Bain Capital Specialty Is Maintained at Equal-Weight by Wells Fargo
Bain Capital Specialty Is Maintained at Equal-Weight by Wells Fargo
Wells Fargo: Maintaining the Bain Capital Specialty (BCSF.US) rating, adjusted from a shareholding wait-and-see rating to a shareholding wait-and-see rating, and the target price was adjusted from $15.00 to $16.00.
Wells Fargo: Maintaining the Bain Capital Specialty (BCSF.US) rating, adjusted from a shareholding wait-and-see rating to a shareholding wait-and-see rating, and the target price was adjusted from $15.00 to $16.00.